Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means The FDA didn't bring peptides back. It opened a formal docket. And that distinction matters. This is not a blanket approval. Not a wellness free for all. Not one announcement that changes everything overnight. The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax